SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-076235
Filing Date
2023-03-22
Accepted
2023-03-22 07:00:29
Documents
14
Period of Report
2023-03-22
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d413566d8k.htm   iXBRL 8-K 25337
2 EX-99.1 d413566dex991.htm EX-99.1 11176
6 GRAPHIC g413566g0321232314170.jpg GRAPHIC 2658
  Complete submission text file 0001193125-23-076235.txt   166953

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ka-20230322.xsd EX-101.SCH 2839
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ka-20230322_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ka-20230322_pre.xml EX-101.PRE 11256
8 EXTRACTED XBRL INSTANCE DOCUMENT d413566d8k_htm.xml XML 3435
Mailing Address 219 TERRY AVE. N. SUITE 300 SEATTLE WA 98109
Business Address 219 TERRY AVE. N. SUITE 300 SEATTLE WA 98109 (206) 378-0400
KINETA, INC./DE (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37695 | Film No.: 23751239
SIC: 2834 Pharmaceutical Preparations